Tue, Jul 22, 2014, 7:37 AM EDT - U.S. Markets open in 1 hr 53 mins

Recent

% | $
Click the to save as a favorite.

Dynavax Technologies Corporation Message Board

  • insttrader2 insttrader2 Jun 30, 2013 11:03 PM Flag

    Think about worst case scenario

    Worst case what do you have: FDA asks for another trial of 6,500 patients (the company already stated the data from previous Phase III admissible. The previous trial was 3.500. So you have a new safety trial for 6,500. Now as I stated before, and i will post the link, during the last Phase III DVAX recruited 700 patients in 3 weeks. So they can recruit 1,000 in one month. 6,500 patients could therefore be recruited in 7 months. Is it so hard to imagine DVAX and the FDA come to an agreement on protocol before the end of summer? Could the additional safety trial then commence say in December? If so, then enrollment would be complete by the end of May next year. Moreover, 1/2 of the patients, those recruited in the first 3 months would have received both of their shots and the one year follow up of those would have commenced (they would be a month into treatment -- a month after the second shot. So worst case, by June of next year, enrollment is complete, and the one year follow up for 1/3 of the patients has started. By winter then of next year the company would have interim safety data. Now the company has publicly stated that it cost them 25 million for a study of 2,500. Thus, a study of 6,500 would cost about 60 million. This means, the company could get to interim safety data with the money on hand-- winter of next year. Should that safety data be good, then the company will have no problem raising funds say at 2.50 per share. Sell another 50 million shares at that price and they enough funds to finish the study, file the amended BLA and get to see approval with cash in the bank for a sales team. With a global market of 1.5 billion at 2.50 a share with 250 million shares out the company would have a market cap of 625 million. With approval the company should be 3 times peak sales or 3 billion dollars. You have to think a few steps forward here. Of course another case of Wegners and this is all over. I say buy it and put it away.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
DVAX
1.41-0.01(-0.70%)Jul 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.